IMMX
Immix Biopharma Inc
11.90$
-7.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +114.5% | +6.3% | -13.5% | +156.1% | +2,010.2% | +215.9% | |
| – | – | – | – | – | – | – | |
| – | -57.4% | -49.0% | +3,216.1% | +108.2% | +29.3% | +44.0% | |
| – | -20.7% | +495.8% | +228.3% | +84.1% | +53.7% | +20.3% | |
| – | -46.1% | +197.9% | +507.9% | +96.4% | +40.5% | +32.1% | |
| – | – | – | – | – | – | – | |
| – | -7.3% | +76.4% | -99.7% | -100.0% | – | – | |
| – | – | – | – | – | – | – | |
| – | -14.6% | -65.7% | +70.8% | +157.3% | +55.4% | -8.1% | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.